Ki‐Ryang Koh

1.0k total citations
41 papers, 665 citations indexed

About

Ki‐Ryang Koh is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Ki‐Ryang Koh has authored 41 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 17 papers in Immunology and 11 papers in Genetics. Recurrent topics in Ki‐Ryang Koh's work include T-cell and Retrovirus Studies (12 papers), Acute Myeloid Leukemia Research (10 papers) and Vector-Borne Animal Diseases (10 papers). Ki‐Ryang Koh is often cited by papers focused on T-cell and Retrovirus Studies (12 papers), Acute Myeloid Leukemia Research (10 papers) and Vector-Borne Animal Diseases (10 papers). Ki‐Ryang Koh collaborates with scholars based in Japan, United States and Czechia. Ki‐Ryang Koh's co-authors include Kensuke Ohta, Atae Utsunomiya, Kazuhide Takeuchi, Takashi Omura, Tetsuya Hayashi, Sakiko Inamoto, Yasuhiro Nakamura, Kaname Akioka, Yasushi Kitaura and Yasukatsu Izumi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ki‐Ryang Koh

37 papers receiving 656 citations

Peers

Countries citing papers authored by Ki‐Ryang Koh

Since Specialization

Citations

This map shows the geographic impact of Ki‐Ryang Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ki‐Ryang Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ki‐Ryang Koh more than expected).

Fields of papers citing papers by Ki‐Ryang Koh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ki‐Ryang Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ki‐Ryang Koh. The network helps show where Ki‐Ryang Koh may publish in the future.

Co-authorship network of co-authors of Ki‐Ryang Koh

This figure shows the co-authorship network connecting the top 25 collaborators of Ki‐Ryang Koh. A scholar is included among the top collaborators of Ki‐Ryang Koh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ki‐Ryang Koh. Ki‐Ryang Koh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for older patients with adult T-cell leukemia/lymphoma 2025 ·Blood ·Makoto Yoshimitsu, Ilseung Choi, Shigeru Kusumoto, Mototsugu Shimokawa, Atae Utsunomiya, Youko Suehiro, Tomonori Hidaka, Kisato Nosaka, Hidenori Sasaki, Shinya Rai, Shinobu Tamura, (unknown), Ki‐Ryang Koh, (unknown), Masahito Tokunaga, Masaaki Sekine, Yuma Sakamoto, Hiroshi Inagaki, Takashi Ishida, Kenji Ishitsuka	5
2	Integrative analysis of ATAC-seq and RNA-seq for cells infected by human T-cell leukemia virus type 1 2025 ·PLoS Computational Biology ·Azusa Tanaka, (unknown), Hiroki Ohta, Norihiro Takenouchi, (unknown), Ki‐Ryang Koh, (unknown), (unknown), Akihiro Fujimoto, Jun‐ichirou Yasunaga, Masao Matsuoka	1
3	Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses 2024 ·Proceedings of the National Academy of Sciences ·(unknown), Jun‐ichirou Yasunaga, Kei Sato, Kisato Nosaka, (unknown), Miho Watanabe, (unknown), Yoshio Koyanagi, Edward L. Murphy, Roberta Bruhn, Ki‐Ryang Koh, Hirofumi Akari, Terumasa Ikeda, Reuben S. Harris, Patrick L. Green, Masao Matsuoka	13
4	Methotrexate‑associated B‑cell lymphoproliferative disease that exhibits hematuria due to urinary bladder lesions: A case report 2024 ·PubMed ·Masahiro Manabe, Yuki Nagano, Takahiro Okuno, Takeshi Inoue, Ki‐Ryang Koh	0
5	Anti‐HTLV‐1 immunity combined with proviral load as predictive biomarkers for adult T‐cell leukemia‐lymphoma 2023 ·Cancer Science ·(unknown), Jun‐ichirou Yasunaga, L. Liang, (unknown), (unknown), Shinji Nakaoka, Shingo Iwami, Yasunori Kogure, Yuta Ito, Keisuke Kataoka, Masanori Nakagawa, Masako Iwanaga, Atae Utsunomiya, Ki‐Ryang Koh, Toshiki Watanabe, Kisato Nosaka, Masao Matsuoka	7
6	Dutcher bodies in an IgA‐myeloma patient harbouring the FGFR3/IGH fusion 2023 ·SHILAP Revista de lepidopterología ·Masahiro Manabe, (unknown), (unknown), (unknown), (unknown), Ki‐Ryang Koh	1
7	A rare der(10)t(X;10)(p11.2;p11.2) in an elderly patient with therapy‐related acute myelomonocytic leukemia 2021 ·SHILAP Revista de lepidopterología ·Masahiro Manabe, (unknown), (unknown), (unknown), (unknown), Ki‐Ryang Koh	1
8	Hodgkin-like adult T-cell leukemia/lymphoma that developed during the follow-up of HTLV-1 associated myelopathy/tropical spastic paraparesis 2019 ·Journal of Clinical and Experimental Hematopathology ·(unknown), Masahiro Yoshida, (unknown), (unknown), (unknown), Takuro Yoshimura, Yoshiki Hayashi, Takafumi Nakao, Ki‐Ryang Koh, Daisuke Niino, Takeshi Inoue, Takahisa Yamane	2
9	Dasatinib Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation for an Isolated Central Nervous System Blast Crisis in Chronic Myelogenous Leukemia 2013 ·Acta Haematologica ·Mitsutaka Nishimoto, Hirohisa Nakamae, Ki‐Ryang Koh, (unknown), Kana Matsumoto, Kunihiko Morita, Hideo Koh, Takahiko Nakane, Masahiko Ohsawa, Masayuki Hino	17
10	Reduced-intensity conditioning by fludarabine/busulfan without additional irradiation or T-cell depletion leads to low non-relapse mortality in unrelated bone marrow transplantation 2011 ·International Journal of Hematology ·Takahiko Nakane, Hirohisa Nakamae, Hideo Koh, Mika Nakamae, Yoshiki Hayashi, Mitsutaka Nishimoto, Takuro Yoshimura, Eri Inoue, Atsushi Inoue, (unknown), (unknown), Yoshiki Terada, Ki‐Ryang Koh, Takahisa Yamane, Masayuki Hino	7
11	Serum Cytokine Profiles at the Onset of Severe, Diffuse Alveolar Hemorrhage Complicating Allogeneic Hematopoietic Stem Cell Transplantation, Treated Successfully with Pulse Intravenous Cyclophosphamide 2010 ·Acta Haematologica ·Hideo Koh, Hirohisa Nakamae, Ki‐Ryang Koh, Masahiko Ohsawa, Takahiko Nakane, (unknown), (unknown), (unknown), (unknown), Yoshiki Terada, Takahisa Yamane, Masayuki Hino	8
12	Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan 2010 ·Blood ·Masako Iwanaga, Toshiki Watanabe, Atae Utsunomiya, Akihiko Okayama, Kaoru Uchimaru, Ki‐Ryang Koh, Masao Ogata, Hiroshi Kikuchi, Yasuko Sagara, Kimiharu Uozumi, Manabu Mochizuki, Kunihiro Tsukasaki, Yoshio Saburi, Masaomi Yamamura, Junji Tanaka, Yukiyoshi Moriuchi, Shigeo Hino, Shimeru Kamihira, Kazunari Yamaguchi, (unknown)	255
13	Heart rate variability during and after peripheral blood stem cell leukapheresis in autologous transplant patients and allogeneic transplant donors 2010 ·International Journal of Hematology ·Takahiko Nakane, Hirohisa Nakamae, Hideo Koh, Mika Nakamae, (unknown), Yoshiki Terada, Ki‐Ryang Koh, Takahisa Yamane, Masayuki Hino	2
14	Cardiac and autonomic nerve function after reduced-intensity stem cell transplantation for hematologic malignancy in patients with pre-transplant cardiac dysfunction 2009 ·Annals of Hematology ·Takahiko Nakane, Hirohisa Nakamae, Takashi Muro, Hiroyuki Yamagishi, Yoshiki Kobayashi, (unknown), Erina Sakamoto, Yoshiki Terada, Mika Nakamae, Ki‐Ryang Koh, Takahisa Yamane, Minoru Yoshiyama, Masayuki Hino	0
15	Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma 2009 ·Journal of Experimental & Clinical Cancer Research ·Yoshiki Terada, Hirohisa Nakamae, (unknown), (unknown), Erina Sakamoto, (unknown), Eri Inoue, Hideo Koh, Takahiko Nakane, (unknown), Masahiko Ohsawa, Ki‐Ryang Koh, Takahisa Yamane, Yoshitaka Nakao, Kensuke Ohta, Atsuko Mugitani, Hirofumi Teshima, Masayuki Hino	49
16	A case of a long‐time survivor with chronic active Epstein–Barr virus infection 2003 ·European Journal Of Haematology ·(unknown), Yoshitaka Nakao, Misako Ueda, Ki‐Ryang Koh, Yasutaka Aoyama, Hirohisa Nakamae, (unknown), Kensuke Ohta, Takayuki Takubo, Takahisa Yamane, Masayuki Hino, Y. Tokura, Shigehiko Ishihara, Koichi Oshima, Hiroshi Kimura, Shinsaku Imashuku	2
17	Differential effects of fibroblast growth factor-4, epidermal growth factor and transforming growth factor-β1 on functional development of stromal layers in acute myeloid leukemia 2002 ·Leukemia Research ·Ki‐Ryang Koh, Kensuke Ohta, Hirohisa Nakamae, Masayuki Hino, Takahisa Yamane, Takayuki Takubo, Noriyuki Tatsumi	2
18	Nodal Gamma/Delta T Cell Lymphoma in Complete Remission following Allogeneic Bone Marrow Transplantation from an HLA-Matched Unrelated Donor 2001 ·Acta Haematologica ·Yasutaka Aoyama, Takahisa Yamane, Masayuki Hino, (unknown), Taro Hasegawa, Chikahiko Sakamoto, Hirohisa Nakamae, (unknown), Ki‐Ryang Koh, (unknown), Takeshi Inoue, Kazuo Tsubaki, (unknown)	4
19	Automated bone marrow analysis using the CD4000 automated haematology analyser 2000 ·Journal of Analytical Methods in Chemistry ·(unknown), Takahisa Yamane, Masayuki Hino, Kensuke Ohta, Ki‐Ryang Koh, Izumi Tsuda, Takayuki Takubo, Noriyuki Tatsumi	8
20	Comparative Study on Complete Remission Rate and Overall Survival in Three Groups Classified Based on the Serum Interleukin-18 Level in Non-Hodgkin’s Lymphoma Patients 2000 ·Acta Haematologica ·Takayuki Takubo, (unknown), Takafumi Nakao, Hirohisa Nakamae, Yasutaka Aoyama, (unknown), (unknown), Ki‐Ryang Koh, Kensuke Ohta, Takahisa Yamane, Masayuki Hino, (unknown), Noriyuki Tatsumi	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact